According to the new market research report by IMARC Group, the global dry eye syndrome market size reached US$ 4.5 Billion in 2022. Looking forward, the market expected to reach US$ 6.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.67% during 2023-2028.
Dry eye syndrome refers to a condition wherein the tears are not able to provide adequate lubrication to the eyes and cause inflammation and damage to the surface of the eye. It comprises various symptoms, such as burning sensation, redness, difficulty in night-time driving, fatigue, blurry vision, discomfort wearing contact lenses, stringy mucus discharge, sensitivity to light, and pain in the eyes. It can be treated through artificial tears, lacrimal plugs, surgery, and consuming prescribed medications.
Download a free sample report to get a detailed overview of the report: https://www.imarcgroup.com/dry-eye-syndrome-market/requestsample
Dry Eye Syndrome Market Trends:
At present, the increasing prevalence of dry eye disorder among the masses due to the inadequate balanced diet and usage of screens and contact lenses represents one of the key factors contributing to the market growth. Besides this, various initiatives undertaken by public and private organizations to spread awareness among the masses about dry eye syndrome and its treatments are offering a positive market outlook. Apart from this, the wide availability of dry eye syndrome medications through hospitals, online stores, and pharmacies is propelling the growth of the market. Moreover, the increasing demand for dry eye syndrome treatments among the geriatric population, as the ability of the lacrimal glands to produce tears decreases with the growing age, is bolstering the growth of the market.
Ask Analyst for 10% free customized report: https://www.imarcgroup.com/dry-eye-syndrome-market
The report cover the below key market segments:
Breakup by Disease Type:
Breakup by Drug Type:
Breakup by Product:
Breakup by Distribution Channel:
Breakup by Region:
Competitive Landscape:
The competitive landscape of the market has also been examined with some of the key players being, Akorn Operating Company LLC, Alimera Science, Allergan plc., Auven Therapeutics, Bausch + Lomb Incorporated, GlaxoSmithKline plc, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., and Santen Pharmaceutical Co. Ltd.
Browse more healthcare industry reports:
Biopsy Devices Market: https://www.imarcgroup.com/biopsy-devices-market
Vision Care Market: https://www.imarcgroup.com/vision-care-market
Media ContactCompany Name: IMARC GroupContact Person: Elena AndersonEmail: Send EmailPhone: +1-631-791-1145Address:30 N Gould St Ste R City: SheridanState: WYCountry: United StatesWebsite: https://www.imarcgroup.com
